Canntab Therapeutics CTABF Stock
Canntab Therapeutics Price Chart
Canntab Therapeutics CTABF Financial and Trading Overview
| Canntab Therapeutics stock price | 0.0001 USD |
| Previous Close | 0.008 USD |
| Open | 0.0083 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.008 - 0.008 USD |
| 52 Week Range | 0.0079 - 0.2 USD |
| Volume | 25K USD |
| Avg. Volume | 2.92K USD |
| Market Cap | 438.29K USD |
| Beta (5Y Monthly) | 0.814814 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.06 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | March 8, 2016 |
| 1y Target Est | N/A |
CTABF Valuation Measures
| Enterprise Value | 2.19M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.9651313 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 29.813 |
| Enterprise Value/EBITDA | -0.723 |
Trading Information
Canntab Therapeutics Stock Price History
| Beta (5Y Monthly) | 0.814814 |
| 52-Week Change | -96.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.2 USD |
| 52 Week Low | 0.0079 USD |
| 50-Day Moving Average | 0.01 USD |
| 200-Day Moving Average | 0.03 USD |
CTABF Share Statistics
| Avg. Volume (3 month) | 2.92K USD |
| Avg. Daily Volume (10-Days) | 2.56K USD |
| Shares Outstanding | 38.91M |
| Float | 33M |
| Short Ratio | N/A |
| % Held by Insiders | 13.74% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:200 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | May 31, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | May 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -4731.089% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -69.60% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 73.48K USD |
| Revenue Per Share (ttm) | 0.002 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -939011 USD |
| EBITDA | -3028307 USD |
| Net Income Avi to Common (ttm) | -3355501 USD |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.81K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 1.9M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.108 |
| Book Value Per Share (mrq) | -0.056 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1401236 USD |
| Levered Free Cash Flow (ttm) | -612491 USD |
Profile of Canntab Therapeutics
| Country | United States |
| State | ON |
| City | Markham |
| Address | 223 Riviera Drive |
| ZIP | L3R 5J6 |
| Phone | N/A |
| Website | https://canntab.ca |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Canntab Therapeutics Limited, a phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada. It offers oral dosage formulations of pharmaceutical cannabis, including sustained release cannabinoid formulations and pellets, immediate release cannabidiol formulations, modified-release multi-layer cannabinoid formulations, flash-melt cannabinoid formulations, and bi-layer cannabinoid tablets for treating sleep disorders, post-traumatic stress disorder, social anxiety, addiction, arthritis, general pain, pain management and appetite loss associated with cancer treatments, and addiction treatment therapy of opioids and other painkillers. Canntab Therapeutics Limited is headquartered in Markham, Canada.
Q&A For Canntab Therapeutics Stock
What is a current CTABF stock price?
Canntab Therapeutics CTABF stock price today per share is 0.0001 USD.
How to purchase Canntab Therapeutics stock?
You can buy CTABF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Canntab Therapeutics?
The stock symbol or ticker of Canntab Therapeutics is CTABF.
Which industry does the Canntab Therapeutics company belong to?
The Canntab Therapeutics industry is Drug Manufacturers-Specialty & Generic.
How many shares does Canntab Therapeutics have in circulation?
The max supply of Canntab Therapeutics shares is 1.47B.
What is Canntab Therapeutics Price to Earnings Ratio (PE Ratio)?
Canntab Therapeutics PE Ratio is now.
What was Canntab Therapeutics earnings per share over the trailing 12 months (TTM)?
Canntab Therapeutics EPS is -0.06 USD over the trailing 12 months.
Which sector does the Canntab Therapeutics company belong to?
The Canntab Therapeutics sector is Healthcare.